IMARC Group, a leading market research company, has recently releases report titled, “Acne Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028“, The study provides a detailed analysis of the industry, including the global acne drugs market growth, share, size and trends forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights

How big is the acne drugs market?

The global acne drugs market size reached US$ 6.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 9.2 Billion by 2028, exhibiting a growth rate (CAGR) of 5.3% during 2023-2028.

What is acne drugs?

Acne refers to a common skin condition that occurs when hair follicles become plugged with oil and dead skin cells and cause whiteheads, blackheads, lumps, and pimples. It comprises non-inflammatory and inflammatory acne that can affect permanent scars on the skin. It can also be caused by menstruation, improper diet, emotional stress, hot and humid climate, and allergic cosmetics. Acne can be cured by various prescriptions and consuming over-the-counter (OTC) drugs, such as retinoids, antibiotics, salicylic acid, benzoyl peroxide, and oral contraceptives.

Request Free Sample Report (Exclusive Offer on this report) [imarcgroup.com]

What are the growth prospects and trends in the acne drugs industry?

Presently, the rising prevalence of skin conditions among teenagers and adults around the world represents one of the key factors strengthening the market growth. Besides this, the growing awareness among consumers about numerous acne products and treatment options is offering a positive market outlook. Apart from this, the increasing development of effective acne drugs with minimal side effects and high potential is bolstering the growth of the market. Moreover, the wide availability of acne drugs through various distribution channels, such as pharmacies, drug, and online stores, is offering a lucrative growth opportunity to industry investors. Furthermore, key manufacturers are introducing isotretinoin capsules for patients suffering from recalcitrant nodular acne, which is propelling the growth of the market.

What is included in market segmentation?

The report has segmented the market into the following categories:

Breakup by Acne Type
Comedonal
Inflammatory
Cystic
Postsurgical/Wound

Breakup by Drug Class
Retinoids
Antibiotics
Hormonal Agents
Combination Drugs
Others

Breakup by Drug Type
OTC Drugs
Prescription Drugs

Breakup by Route of Administration
Topical
Oral
Injectable

Breakup by Region
North America
Asia-Pacific
Europe
Latin America
Middle East and Africa

Who are the key players operating in the industry?

The report covers the major market players including:

Allergan Plc
Bausch Health Companies Inc.
Bayer Aktiengesellschaft
Cipher Pharmaceuticals Inc.
Galderma Holding SA
Johnson & Johnson
Pfizer Inc.
Reckitt Benckiser Group Plc
Skinvisible Pharmaceuticals Inc.
Sun Pharmaceutical Industries Limited
Teva Pharmaceutical Industries Ltd.

Ask Analyst for 10% Free Customized Report [imarcgroup.com]

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact us

IMARC Group
Email: sales@imarcgroup.com
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Website: [imarcgroup.com]
Follow us on Twitter: @imarcglobal
Linkedin: [linkedin.com]